High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network.
Marchesi F, Mengarelli A, Giannotti F, Tendas A, Anaclerico B, Porrini R, Picardi A, Cerchiara E, Dentamaro T, Chierichini A, Romeo A, Cudillo L, Montefusco E, Tirindelli MC, De Fabritiis P, Annino L, Petti MC, Monarca B, Arcese W, Avvisati G; Rome Transplant Network.
Marchesi F, et al. Among authors: tirindelli mc.
Transpl Infect Dis. 2014 Feb;16(1):158-64. doi: 10.1111/tid.12162. Epub 2013 Nov 12.
Transpl Infect Dis. 2014.
PMID: 24215479